Sassa bungled and then cancelled a three-year tender to provide food parcels for people in distress last year. With no contracted service providers, Sassa delivered no food parcels in key provinces between November 2019 to March 2020.Former service providers complained of being stranded with warehouses filled with food, but Sassa’s mistake meant no community members…
Sassa has given a lifeline to all rejected applicants of the R350 Covid-19 grant.In early June, close to 50% of processed applications did not qualify in terms of the criteria.More than 2.5 million applicants have already been paid so far from over 3.2 million who applied.The South African Social Security Agency (Sassa) has given a…
Citizens waiting for SASSA (PHOTO:GALLO IMAGES) The SACP wants the R350 Covid-19 social distress relief grant to become a permanent feature. The six-month special grant was announced by President Cyril Ramaphosa in April and is administered by the SA Social Security Agency.After the agency was criticised last month for only managing to pay 10 people during…
GroundUp reported.Others started queuing as early as midnight. On Tuesday they were paid.Mzwakhe Dlamini from Elandskop said he and several others had slept outside the post office because they had no money for transport."A few of us slept outside the post office. Others who didn't have money for transport were assisted by the street hawkers. They…
All the latest coronavirus and lockdown updatesThis after the agency made accidental double payments in some areas and no payments in others owing to "glitches" in its system as it tried to process payments to the elderly and disabled earlier to avoid overcrowding, News24 reported on Monday. Approximately 435 000 people in the Western Cape reportedly received…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.